Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 49:45 Connect with the Experts: Endocrine Series – Delayed Puberty 4 years ago Care Webinars,Webinars 1:04:36 Connect with the Experts: Endocrine Series – Bone Health 4 years ago Care Webinars,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 1:31:01 Resiliency in Results – What We Learn When Trials Are Terminated (September 16, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars 58:11 NS Pharma Announcement of VILTEPSO™ (August 26, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars 52:47 Family Friday: Thriving in the Virtual Classroom 4 years ago Family Friday,Webinars 1:00:32 2020 Back-To-School Series: Thriving in the Virtual Classroom (August 19, 2020) 4 years ago Care Webinars,COVID-19 Webinars,Webinars 48:16 Family Friday: Planning for a Safe and Successful Return to School 4 years ago Family Friday,Webinars 57:12 2020 Back-To-School Series: Planning for a Safe and Successful Return to School (August 12, 2020) 4 years ago Care Webinars,COVID-19 Webinars,Webinars «1…89101112…25»Page 10 of 25
by: Parent Project Muscular Dystrophy
